Grx5 is a mitochondrial glutaredoxin critical for iron-sulfur (Fe-S) cluster biosynthesis and redox homeostasis . Antibodies targeting Grx5 are primarily used in research to study its expression, localization, and interactions.
Function: Facilitates Fe-S cluster assembly in mitochondria, essential for enzymes like aconitase and succinate dehydrogenase .
Cellular Role: Mutations in GRX5 lead to iron accumulation and oxidative stress, impairing Fe-S-dependent enzyme activity .
While no commercial "GRXC5 Antibody" is explicitly documented, studies utilize epitope-tagged variants (e.g., HA-tagged Grx5) and polyclonal antibodies for detection.
| Antibody Type | Target | Application | Source |
|---|---|---|---|
| Anti-HA mAb | HA-tagged Grx5 | Western blot, immunoprecipitation | |
| Polyclonal anti-Grx5 | Native Grx5 | Protein localization in mitochondrial matrix |
Fe-S Cluster Assembly: Grx5-deficient yeast strains show reduced activity of Fe-S enzymes (e.g., aconitase), reversible upon Grx5 reintroduction .
Therapeutic Potential: Dysregulation of Grx5 is linked to mitochondrial disorders, making it a target for metabolic disease research .
Current antibodies against Grx5 are primarily research-grade. Further development of high-affinity monoclonal antibodies could enhance diagnostic and therapeutic applications, particularly in mitochondrial pathologies.